Abraham Susan C, Park Seun Ja, Lee Jae-Hyuk, Mugartegui Lilian, Wu Tsung-Teh
Department of Pathology, Mayo Clinic, Rochester, MN 55905, USA.
Mod Pathol. 2003 Aug;16(8):786-95. doi: 10.1097/01.MP.0000080349.37658.5E.
Gastric adenomas are unusual neoplasms that can constitute one of the direct precursors to gastric adenocarcinoma. Most gastric adenomas are comprised of polypoid projections of dysplastic epithelium with at least focal intestinal-type differentiation (containing goblet cells and/or Paneth cells), whereas adenomas comprised entirely of dysplastic foveolar-type epithelium are rare. It has been shown that nearly all intestinal-type adenomas arise in association with background intestinal metaplasia and gastric atrophy, approximately 40% harbor high-grade dysplasia, and nearly one fourth progress to adenocarcinoma. In contrast, foveolar-type adenomas tend to occur in otherwise normal, nonatrophic gastric mucosa and rarely harbor high-grade dysplasia or carcinoma. Potential differences in the genetic alterations between intestinal-type and foveolar-type gastric adenomas have not been systematically studied. We investigated 11 intestinal-type and 7 foveolar-type gastric adenomas (all from patients without familial adenomatous polyposis) for alterations in APC (using 5q allelic loss assays and direct DNA sequencing of the mutation cluster region), beta-catenin (using direct DNA sequencing of the phosphorylation region in exon 3), K-ras (using direct DNA sequencing of codons 12 and 13), and microsatellite instability (MSI; using fluorescent-based PCR amplification of a standard panel of 5 microsatellite markers). Overall, 10 of 11 (91%) intestinal-type adenomas harbored at least one detectable genetic alteration, whereas only 3 of 7 (43%) of foveolar-type adenomas did (P =.047). However, no statistically significant differences in any particular genetic alteration were found. Among intestinal-type adenomas, APC alterations were present in seven (64%), high-level MSI in three (27%), and K-ras mutations in two (18%). Among foveolar-type adenomas, APC alterations were present in three (43%) and a K-ras mutation in one of six amplifiable polyps (17%). Neither APC nor MSI correlated with the size of the adenoma, but K-ras mutations were found only in lesions of > or = 1 cm. beta-catenin mutations were not present in any gastric adenoma, irrespective of the presence or absence of APC alterations. These results suggest that the types and frequencies of genetic alterations occurring in gastric and colorectal adenomas are similar. Although intestinal-type and foveolar-type gastric adenomas display divergent biologic behavior, the specific genetic events accounting for these differences in morphology and biologic behavior are unclear.
胃腺瘤是一种少见的肿瘤,可构成胃腺癌的直接前体之一。大多数胃腺瘤由发育异常上皮的息肉样突起组成,至少有局灶性肠化生(含杯状细胞和/或潘氏细胞),而完全由发育异常的胃小凹型上皮组成的腺瘤罕见。研究表明,几乎所有肠型腺瘤都与背景肠化生和胃萎缩相关,约40%存在高级别上皮内瘤变,近四分之一会进展为腺癌。相比之下,胃小凹型腺瘤往往发生在其他方面正常的非萎缩性胃黏膜中,很少有高级别上皮内瘤变或癌变。肠型和胃小凹型胃腺瘤之间基因改变的潜在差异尚未得到系统研究。我们研究了11例肠型和7例胃小凹型胃腺瘤(均来自无家族性腺瘤性息肉病的患者),检测其APC基因改变(采用5q等位基因缺失分析和突变簇区域的直接DNA测序)、β-连环蛋白(采用外显子3磷酸化区域的直接DNA测序)、K-ras基因(采用密码子12和13的直接DNA测序)以及微卫星不稳定性(MSI;采用基于荧光的5个微卫星标记标准面板的PCR扩增)。总体而言,11例肠型腺瘤中有10例(91%)存在至少一种可检测到的基因改变,而7例胃小凹型腺瘤中只有3例(43%)存在这种情况(P = 0.047)。然而,在任何特定基因改变方面均未发现统计学上的显著差异。在肠型腺瘤中,7例(64%)存在APC改变,3例(27%)为高度MSI,2例(18%)存在K-ras突变。在胃小凹型腺瘤中,3例(43%)存在APC改变,6例可扩增息肉中有1例(17%)存在K-ras突变。APC和MSI均与腺瘤大小无关,但K-ras突变仅在直径≥1 cm的病变中发现。无论是否存在APC改变,任何胃腺瘤中均未发现β-连环蛋白突变。这些结果表明,胃和结肠腺瘤中发生的基因改变类型和频率相似。尽管肠型和胃小凹型胃腺瘤表现出不同的生物学行为,但导致这些形态和生物学行为差异的具体基因事件尚不清楚。